IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C
Contributeurs/tricesBochud, Pierre-Yves; Bibert, Stéphanie; Negro, Francesco; Haagmans, B; Soulier, Anthony André; Ferrari, C; Missale, G; Zeuzem, S; Pawlotsky, J-M; Schalm, S; Hellstrand, K; Neumann, A U; Lagging, M
Publié dansJournal of hepatology, vol. 55, no. 5, p. 980-988
Date de publication2011
Résumé
Mots-clés
- Adult
- Alleles
- Antiviral Agents/therapeutic use
- Female
- Gene Frequency
- Genotype
- Hepacivirus/genetics/physiology
- Hepatitis C, Chronic/drug therapy/genetics
- Humans
- Interferon-alpha/therapeutic use
- Interleukins/genetics
- Male
- Middle Aged
- Multivariate Analysis
- Polyethylene Glycols/therapeutic use
- Polymorphism, Single Nucleotide/genetics
- RNA, Viral/blood
- Recombinant Proteins/therapeutic use
- Ribavirin/therapeutic use
- Time Factors
Groupe de recherche
Citation (format ISO)
BOCHUD, Pierre-Yves et al. IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C. In: Journal of hepatology, 2011, vol. 55, n° 5, p. 980–988. doi: 10.1016/j.jhep.2011.01.050
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:25376
- DOI : 10.1016/j.jhep.2011.01.050
- PMID : 21354446
ISSN du journal0168-8278